美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
16571-854-03	16571-854	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	21 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-854-03)
16571-855-03	16571-855	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	28 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-855-03)
16571-855-09	16571-855	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	28 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-855-09)
16571-853-09	16571-853	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	14 mg/1	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-853-09)
16571-853-03	16571-853	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	14 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-853-03)
16571-852-03	16571-852	HUMAN PRESCRIPTION DRUG	Memantine Hydrochloride	memantine	CAPSULE, EXTENDED RELEASE	ORAL	20250601	N/A	ANDA	ANDA206032	Rising Pharma Holdings, Inc.	MEMANTINE HYDROCHLORIDE	7 mg/1	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03)